Biotech China 2014
Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies
The Grove Park Inn Resort & Spa
290 Macon Avenue
Asheville, NC
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showFaculty/id/5/conference_id/467
Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies

Schedule of Presentations:

Friday, April 9, 2010
13:00:00 Registration
13:10:00 Simultaneous Session 1 Advanced Practice Nursing: Focus on Chronic Lymphocytic Leukemia
14:00:00 Welcome, Introductions and Presession Survey | Session 2 Patrick Buckley
14:00:00 Simultaneous Session 2 Practical Hematopathology: T-Cell Lymphomas Patrick Buckley
14:00:00 Welcome, Introductions and Presession Survey
14:10:00 Classification of T-Cell Lymphomas | Session 2 Anand Shreeram Lagoo
14:10:00 Pathophysiology and Diagnosis Mark C. Lanasa
14:40:00 Treatment Options Patricia H. Davis
14:40:00 General Principles in Treating T-Cell Lymphomas | Session 2 Anne W. Beaven
15:10:00 Transplantation Therese Hennig
15:10:00 CD30-Positive and Other Cutaneous T-Cell Proliferations | Session 2 Patrick Buckley
15:40:00 The Biologic Significance of Clonal T-Cells | Session 2 Michael B. Datto
15:40:00 Pharmacy Session Tippu Khan
16:10:00 Palliative and End-of-Life Care Gwynn D. Long
16:10:00 Interesting Cases and Postsession Survey | Session 2 Anand Shreeram Lagoo, Patrick Buckley, Anne W. Beaven
16:40:00 Postsession Survey and Question-and-Answer Session
17:00:00 Adjourn
17:00:00 Reception
17:00:00 Reception | Session 2
17:00:00 Adjourn | Session 2
Saturday, April 10, 2010
07:30:00 Registration and Continental Breakfast
07:40:00 Leukemia Session Joseph Moore
08:00:00 Welcome and Presession Survey Joseph Moore
08:10:00 Debate Patients With Philadelphia Chromosome–Positive ALL: Transplant Now or Later? Anjali S. Advani, Gwynn D. Long
08:50:00 The Future of Personalized Therapy: The Application of Genomics and MicroRNA in Guiding Therapy Sandeep S. Dave
09:20:00 Debate Allogeneic Transplantation Is Standard for All Patients Aged < 55 Years With AML in First Remission Who Do Not Have Good-Risk Cytogenetics Jon Gockerman, Nelson J. Chao
10:05:00 Break
10:15:00 Case-Based Presentation Myeloproliferative Neoplasms: What Are We All JAKed Up About? Murat O. Arcasoy, Richard T. Silver
10:50:00 Debate The Best Therapy for Elderly Patients With AML: 7+3 Is Good Enough for Me! Joseph Moore, Arati Rao
11:40:00 Lunch
11:45:00 Bone Marrow Transplantation Workshop Nelson J. Chao
12:30:00 Debate Transplantation vs. Novel, Less Lethal Approaches to MDS Mitchell Horwitz, Carlos de Castro
13:15:00 Recent Advances in Cord Blood Transplantation Nelson J. Chao
13:45:00 Recent Advances in Posttransplantation Immune Modulation Following Nonablative Allogeneic Transplantation David Rizzieri
14:15:00 Use of New Stem Cell Mobilization Agents for Patients and Healthy Donors Mitchell Horwitz
14:30:00 Question-and-Answer Session/Postsession Survey
14:40:00 Adjourn
Sunday, April 11, 2010
07:30:00 Registration and Continental Breakfast
07:35:00 Lymphoma Session Anne W. Beaven
08:00:00 Welcome and Presession Survey David Rizzieri
08:10:00 Keynote Address New Therapies for PNH Wendell F. Rosse
08:55:00 Use of Radioimmunotherapy as Induction in Follicular Lymphoma Jane Winter
09:25:00 How I Treat High-Risk DLBCL Jane Winter, Anne W. Beaven
10:10:00 Break
10:20:00 Debate Induction Therapy in Preparation for Transplantation: Immunomodulator or Proteasome Inhibitor? Cristina Gasparetto
11:05:00 Debate Fludarabine-Based Regimens Are the Preferred First-line Approach to Patients With CLL Mark C. Lanasa, David Rizzieri
11:50:00 Question-and-Answer Session/Postsession Survey
12:00:00 Adjourn
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.